ERBB3 -rs2292239 as primary type 1 diabetes association locus among non- HLA genes in Chinese-Reference-Cited by-同舟云学术

ERBB3 -rs2292239 as primary type 1 diabetes association locus among non- HLA genes in Chinese

Published:2016-09 Issue: Volume:9 Page:120-123
ISSN:2214-5400
Container-title:Meta Gene
language:en
Short-container-title:Meta Gene

Author:

Sun Chengjun^ORCID,Wei Haiyan,Chen Xiuli,Zhao Zhuhui,Du Hongwei,Song Wenhui,Yang Yu,Zhang Miaoying,Lu Wei,Pei Zhou,Xi Li,Yan Jian,Zhi Dijing,Cheng Ruoqian,Luo Feihong

Funder

Chinese Scholarship Council

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference25 articles.

1. Type 1 diabetes;Atkinson;Lancet,2014

2. Feedback regulation of EGFR signalling: decision making by early and delayed loops;Avraham;Nat. Rev. Mol. Cell Biol.,2011

3. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes;Barrett;Nat. Genet.,2009

4. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci;Bradfield;PLoS Genet.,2011

5. T1DBase: update 2011, organization and presentation of large-scale data sets for type 1 diabetes research;Burren;Nucleic Acids Res.,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic applications of CRISPR-Cas9 in diabetes mellitus: a perspective review;Minerva Biotechnology and Biomolecular Research;2024-01

2. A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-31

3. CTLA4,SH2B3, andCLEC16Adiversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients;Clinical and Experimental Immunology;2023-01-09

4. Arid1a loss potentiates pancreatic β-cell regeneration through activation of EGF signaling;Cell Reports;2022-11

5. The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients;Microvascular Research;2022-09